Stock listing

OTC:CBSC Cardiac Biotech Solutions Inc. Stock

Follow Cardiac Biotech Solutions Inc. into a list and get an email when it puts out news.

Share price · OTC:CBSC

$0.035 USD 0.000 (0.0%)

Close on Nov 9, 2026

Past year +7.8% · daily closes, Nov 10, 2025 – Nov 9, 2026, adjusted for splits
Day range
$0.035 – $0.035 USDNov 9, 2026
Volume
15,000 sharesNov 9, 2026
Market cap
$5.88M USDAt the close on Nov 9, 2026 · price × 170.4M shares outstanding
52-week range
$0.016 – $0.063 USDLowest and highest trades, Nov 10, 2025 – Nov 9, 2026
Traded on an average day
$625 USDMedian day 0 shares · 36 days with no trades · last 3 months, Aug 10, 2026 – Nov 9, 2026
Cardiac Biotech Solutions Inc. logo

Daily closes

Last 3 months, Aug 10, 2026 – Nov 9, 2026 · OTC:CBSC · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.0350.0000.0%$0.035$0.035$0.03515,000
$0.035+0.004+13.1%$0.035$0.035$0.0354,994
$0.031+0.000+0.7%$0.031$0.031$0.03111,300
$0.030-0.003-8.2%$0.035$0.035$0.030102,000
$0.0330.0000.0%$0.033$0.033$0.0330
$0.0330.0000.0%$0.033$0.033$0.0330
$0.0330.0000.0%$0.033$0.033$0.0330
$0.033-0.003-8.3%$0.033$0.033$0.03315,000
$0.0360.0000.0%$0.036$0.036$0.0360
$0.0360.0000.0%$0.036$0.036$0.0360
$0.0360.0000.0%$0.036$0.036$0.0360
$0.0360.0000.0%$0.036$0.036$0.0360
$0.036+0.001+2.9%$0.035$0.036$0.03514,200
$0.0350.0000.0%$0.035$0.035$0.0350
$0.0350.0000.0%$0.035$0.035$0.0350
$0.0350.0000.0%$0.035$0.035$0.0350
$0.0350.0000.0%$0.035$0.035$0.0350
$0.0350.0000.0%$0.035$0.035$0.0350
$0.0350.0000.0%$0.035$0.035$0.0350
$0.0350.0000.0%$0.035$0.035$0.0350
$0.0350.0000.0%$0.035$0.035$0.0350
$0.035+0.004+12.9%$0.035$0.035$0.03563,300
$0.0310.0000.0%$0.031$0.031$0.0310
$0.0310.0000.0%$0.031$0.031$0.0310
$0.0310.0000.0%$0.031$0.031$0.0310
$0.0310.0000.0%$0.031$0.031$0.0310
$0.031-0.005-13.9%$0.039$0.039$0.030520,700
$0.0360.0000.0%$0.036$0.036$0.0360
$0.0360.0000.0%$0.036$0.036$0.0360
$0.0360.0000.0%$0.036$0.036$0.0360
$0.0360.0000.0%$0.036$0.036$0.03630,000
$0.0360.0000.0%$0.036$0.036$0.0362,000
$0.0360.0000.0%$0.036$0.036$0.036300
$0.0360.0000.0%$0.036$0.036$0.0360
$0.0360.0000.0%$0.036$0.036$0.0360
$0.0360.0000.0%$0.036$0.036$0.0360
$0.0360.0000.0%$0.036$0.036$0.03630,000
$0.0360.0000.0%$0.036$0.036$0.0360
$0.0360.0000.0%$0.036$0.036$0.0360
$0.0360.0000.0%$0.036$0.036$0.0360
$0.036-0.004-10.0%$0.036$0.036$0.0361,000
$0.0400.0000.0%$0.040$0.040$0.04010,000
$0.0400.0000.0%$0.040$0.040$0.0400
$0.0400.0000.0%$0.040$0.040$0.0400
$0.0400.0000.0%$0.040$0.040$0.0400
$0.0400.0000.0%$0.040$0.040$0.0400
$0.0400.0000.0%$0.040$0.040$0.040100,000
$0.040+0.002+5.3%$0.040$0.040$0.03699,300
$0.038+0.002+5.6%$0.038$0.038$0.03810,700
$0.0360.0000.0%$0.036$0.036$0.0360
$0.036+0.003+9.1%$0.040$0.040$0.03622,300
$0.0330.0000.0%$0.033$0.033$0.033100
$0.0330.0000.0%$0.033$0.033$0.0330
$0.033-0.004-10.8%$0.035$0.035$0.033200
$0.037+0.013+54.2%$0.035$0.037$0.03523,400
$0.0240.0000.0%$0.024$0.024$0.0240
$0.0240.0000.0%$0.024$0.024$0.0240
$0.024-0.006-20.0%$0.024$0.024$0.024100

Splits

3 splits since 1997 · OTC:CBSC · every price before a split is adjusted for it

DayRatioWhat
1-for-75Consolidation
1-for-5Consolidation
2-for-1Split
Ticker
OTC:CBSC
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
OTC
Currency
USD

What changed lately

Latest news

All Cardiac Biotech Solutions Inc. news

Cardiac Biotech Solutions Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
1 in the last 12 months · 47 in all · newest Jan 15, 2026 · oldest 2016

Valuation

EV/sales 43.3× against a median of 0.4×: 5th lowest of 6 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 9, 2026

Enterprise value
$6.41M USD
P/E
Loss
EV/sales
43.3×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Negative equity
Gross margin
Not reported
Operating margin
−725.5%
Net margin
−578.0%
Debt to equity
Negative equity
Beta vs S&P 500
0.36

Medical devices & supplies: the 10 companies nearest in size, of 449 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Cardiac Biotech Solutions Inc. · OTC:CBSCUS$5.88MUS$6.41Mn/a43.3×n/an/a−578.0%n/a0.36
Airway Medix SA · GPW:AWMUS$6.73MUS$10.07Mn/a278×n/an/an/an/an/a
Surgical Innovations Group plc · LSE:SUNUS$6.71MUS$7.01Mn/a0.5×n/a0.7×−7.7%0.1×n/a
Izotropic Corp. · CSE:IZOUS$6.30MUS$6.26Mn/an/an/an/an/an/a0.21
Accuray Incorporated · NASDAQ:ARAYUS$6.20MUS$65.61Mn/a0.2×n/a0.1×−4.4%1.9×2.46
NeuroOne Medical Technologies Corporation · NASDAQ:NMTCUS$5.94MUS$3.89Mn/a0.4×n/a1.6×−78.6%0.0×1.07
Neola Medical AB · OMXSTO:NEOLAUS$5.46MUS$5.06Mn/an/an/a0.6×n/a0.0×n/a
ENDRA Life Sciences Inc. · NASDAQ:NDRAUS$5.36MUS$3.85Mn/an/an/a1.0×n/a0.0×1.07
MEKICS Co., Ltd. · KRX:058110US$5.26MUS$2.05M6.6×0.2×1.3×0.2×7.7%0.1×n/a
PT Hetzer Medical Indonesia Tbk · IDX:MEDSUS$5.13MUS$5.42Mn/an/an/a1.8×n/a0.1×n/a
Regentis Biomaterials Ltd. · AMEX:RGNTUS$5.05M−US$3.90Mn/an/an/a0.7×n/a0.0×2.00
Median of the othersUS$5.70MUS$5.24M6.6×0.4×1.3×0.7×−6.1%0.0×1.07

Team and board

Officers

OfficerRole
Charles K MartinChief Executive Officer, President and Director
William Griffin ThomasChief Financial Officer and Treasurer

Board

DirectorRole
Paul K DannerChairman of the Board of Directors and Independent Director
Charles K MartinChief Executive Officer, President and Director
James E OttIndependent Director

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue152.7K41.4K135.1K82.4K75.6K32.4K121.9K58.7K36.6K33.0K
Cost of revenue0042.2K149.2K9.81K720.0K43.8K414.7K227.3K
Gross profit41.4K135.1K40.2K-73.7K22.6K-598.1K14.8K-378.0K-194.4K
Research and development27.5K173.2K419.7K485.0K00
Selling, general and administrative1.20M1.31M2.14M1.80M2.96M89160
Operating income-1.16M-1.33M-1.60M-2.10M-1.87M-2.94M-999.5K-62.6K-481.4K-369.8K
Depreciation and amortization29.3K06116.75K171.9K3.02K3.33K481
EBITDA-1.57M-2.10M-1.87M-2.94M-827.6K-59.5K-478.1K-369.3K
Interest expense252.9K222.4K5.29K5.21K1.54M344.3K00
Income before tax-896.0K-1.68M-1.63M-2.11M-6.34M-4.33M-999.5K-62.6K-1.13M-386.0K
Income tax-227.9K1.54M344.3K-171.9K-4-5-1
Net income-896.0K-1.68M-1.63M-2.11M-6.34M-4.33M-999.5K-62.6K-1.13M-386.0K
Earnings per share, basic-0.01-0.01-0.01-0.02-0.07-0.06-0.02-0.00-0.02-0.01

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents3.86K50.0K126.0K136.5K427.0K18.7K15.0K7.59K4.67K12.5K
Short-term investments00
Receivables88.4K6.50K4.68K3.85K91.6K13.2K12.7K11.3K10.8K6.88K
Inventory160.8K27.9K27.9K23.4K9.27K154.3K80.9K13.1K14.8K22.8K
Current assets494.1K92.4K175.4K179.8K529.0K311.2K108.6K31.9K30.3K42.1K
Property, plant and equipment5.40K885
Goodwill00
Total assets494.1K167.4K300.4K304.8K654.0K311.8K108.6K36.0K60.6K67.6K
Accounts payable230.4K73.8K32.6K24.0K9.77K9.21K13.6K99.9K149.2K148.4K
Current liabilities2.22M2.02M825.8K681.7K164.8K496.6K275.5K1.07M1.27M585.8K
Long-term debt5.10K00
Total debt537.5K263.1K20.9K100.0K43.8K388.8K1.80M356.8K513.9K246.3K
Total liabilities2.79M2.12M943.2K681.7K164.8K501.7K2.08M1.07M1.27M585.8K
Shareholders' equity-2.29M-1.96M-642.8K-376.9K489.1K-189.9K-1.97M-1.03M-1.21M-518.1K
Shares outstanding164.7M158.8M139.6M119.1M91.2M77.9M58.6M58.0M58.0M57.1M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-636.7K-1.25M-1.19M-786.0K-662.6K-682.7K-108.7K-768.7K-62.5K
Capital spending00-100000-6.35K-535
Free cash flow-636.7K-1.25M-1.19M-786.0K-662.6K-682.7K-108.7K-775.1K-63.0K
Cash from investing40.0K-40.0K-125.0K24.3K-6.35K-535
Cash from financing590.5K1.24M856.5K1.23M791.3K600.2K87.3K767.3K75.7K
Dividends paid00
Share buybacks00
Change in cash-46.2K-10.4K-290.5K408.3K3.75K7.37K2.93K-7.83K12.7K

Open Financials

Cap table

Built by 6ix from Cardiac Biotech Solutions Inc.’s releases

Common shares
170,438,574
Fully diluted
170,438,574

Fully diluted

LineShares
Common shares170,438,574

Share count over time

CountShares
Nov 22, 2026170,438,574

Open Cap table

Log in to ask 6ix AI your own questions about Cardiac Biotech Solutions Inc.